Industry News
Pharmaceutical Industry News
Tomar ‘microdosis’ de Ozempic es tentador. ¿Funciona?
Algunas personas toman cantidades minúsculas de fármacos para adelgazar con la esperanza de perder peso sin sufrir los efectos secundarios. Esto dicen los expertos.
The Allure of ‘Microdosing’ Ozempic
Some people are taking tiny amounts of weight loss medications, hoping to drop pounds while avoiding side effects. Does it work?
Is It Time to Worry About Benzene in Personal Care Products?
The carcinogen has been found in sunscreen, deodorants, acne creams and other personal care products. Here’s what to know.
Experts Say GLP-1 Drugs Have Potential Use Beyond Weight Loss
Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed the potential for wildly popular weight-loss drugs to be used to treat many other conditions.
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance
The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety.
Trump Wants to Shake Up Health Care. Many Americans Don’t Mind.
Some voters galvanized by Robert F. Kennedy Jr.’s pledge to “Make America Healthy Again” said they believed the health establishment was dismissive and even corrupt.
Long a ‘Crown Jewel’ of Government, N.I.H. Is Now a Target
The agency long benefited from broad bipartisan support. But Republican criticism has intensified, and new choices for top health posts hope to upend the organization.
¿Cómo funciona el Ozempic?
Te compartimos una guía sobre este y otros medicamentos populares utilizados para la diabetes y la pérdida de peso.
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
RFK Jr.’s Ideas on Big Pharma and Food Align With Some of Trump’s Biggest Critics
When it comes to weeding out corporate influence, Robert F. Kennedy Jr.’s ideas often align best with some of Trump’s loudest critics.
Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.
New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows
The drug, which is named MariTide and delivered in a monthly injection, is some time away from being sold.
A Kennedy no le gusta Ozempic, esto es lo que podría hacer al respecto
El presidente electo Donald Trump está listo para nominar a Robert F. Kennedy Jr. para que lidere el Departamento de Salud y Servicios Humanos, donde tendría un poder limitado sobre los medicamentos.
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Dr Martin Makary Chosen to Head the FDA
A frequent Fox News commentator, Dr. Makary has a penchant for challenging the medical establishment, and stirred pandemic concerns with his views on Covid immunity and vaccine mandates.
Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Know
President-elect Donald J. Trump is set to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department, where he would have limited power over drugs.
F.D.A.: Some Clonazepam Recalled Over Incorrect Doses on Labels
The drug, known by the brand name Klonopin, is used for panic disorder and seizures.
The New York Times Presents: ‘Weight of the World’ on Ozempic’s Rise
As GLP-1 medications like Ozempic soar in popularity, our new documentary follows three people on their weight-loss journeys — and explores how decades of diet culture paved the way for the drugs’ rise.
Trump’s New Pick for Attorney General, and a Surprise Turn in U.S. Drug Deaths
Plus, a “Wicked” warning.
Orders for Morning-After Pills and Abortion Pills Rise After Trump’s Election
Some women are stocking up on the medications, saying they are concerned that the new administration could take steps to restrict access.